secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xencor Inc (XNCR)
CIK:        0001326732
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001326732-23-000038
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xencor sells Ultomiris and Monjuvi royalty rights to OMERS for $215M upfront
----------------------------------------------------------------------------

- OMERS pays $192.5M for Ultomiris royalties from July 2023 through end-2025, then annual caps starting in 2026.
- OMERS pays $22.5M for Monjuvi royalties until OMERS receives 1.3x purchase price; excess reverts to Xencor.
- Xencor eligible for an additional $12M milestone from OMERS if certain Ultomiris sales targets met.
- Xencor retains economic upside above annual royalty caps ($35M from 2026-2028, $12M from 2029 onward).
- Cash proceeds strengthen balance sheet to fund internal pipeline programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326732/000132673223000038/0001326732-23-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326732/000132673223000038/xncr-20231103.htm
  HTML page:      https://secwatch.observer/filing/0001326732-23-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer